Scholar Rock Holding (SRRK) is back in focus after updating investors on an FDA warning letter sent to its manufacturing partner, Catalent Indiana, along with plans to resubmit its biologics license ...

Detailed price information for Cogent Biosciences Inc (COGT-Q) from The Globe and Mail including charting and trades.

Scholar Rock Holding Corporation ( SRRK) Citi Annual Global Healthcare Conference 2025 December 3, 2025 1:00 PM EST ...

In early December 2025, Scholar Rock reported that reported that the Novo Nordisk Bloomington, Indiana site (formerly Catalent Indiana LLC) received an FDA warning letter, while the company still ...

CAMBRIDGE, Mass., November 18, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and ...

Scholar Rock Holding Corp (SRRK) reported its third-quarter earnings for 2025, revealing a mixed financial picture. The company posted an earnings per share (EPS) of -$0.90, slightly missing the ...

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and ...

The company reported $50.5 million in research and development spending for the third quarter, driven by manufacturing investments and higher employee-related expenses. General and administrative ...

On Tuesday, 18 November 2025, Scholar Rock (NASDAQ:SRRK) presented at the Jefferies London Healthcare Conference 2025, discussing both challenges and strategic initiatives. The company addressed a ...